Get Level 2

If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. ENRC.L Share Price
  4. ENRC.L Share Regulatory News
  5. Form 8.5 (EPT/NON-RI) - ENRC

Pin to quick picksENRC.L Regulatory News (ENRC)

ENRC.L Information
  • There is currently no data for ENRC

Form 8.5 (EPT/NON-RI) - ENRC

6 Jun 2013 10:25

RNS Number : 4539G
Societe Generale SA
06 June 2013
 



FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

SOCIETE GENERALE SA

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Eurasian Natural Resources Corp Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Mr. Alexander Machkevitch, Mr. Alijan Ibragimov, Mr. Patokh Chodiev and the Kazakh Government

(d) Date position held/dealing undertaken:

05/06/2013

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

YES: Kazakhmys Plc

 

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

USD 0.20 Ordinary share

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

595,068

0.05

73,800

0.01

(2) Derivatives (other than options):

0

0.00

2,000

0.00

(3) Options and agreements to purchase/sell:

0

 

0.00

0

 

0.00

TOTAL:

595,068

0.05

75,800

0.01

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

(GBP)

Ordinary share

Purchase

3,701

2.4380

Ordinary share

Purchase

973

2.4350

Ordinary share

Purchase

1,893

2.4550

Ordinary share

Purchase

3,587

2.4270

Ordinary share

Purchase

213

2.4430

Ordinary share

Purchase

2,593

2.4600

Ordinary share

Purchase

1,780

2.4430

Ordinary share

Purchase

575

2.4530

Ordinary share

Purchase

192

2.4240

Ordinary share

Purchase

524

2.4630

Ordinary share

Purchase

1,664

2.4380

Ordinary share

Purchase

1,829

2.4720

Ordinary share

Purchase

2,466

2.4380

Ordinary share

Purchase

3,652

2.4430

Ordinary share

Purchase

2,676

2.4440

Ordinary share

Purchase

450

2.4380

Ordinary share

Purchase

767

2.4430

Ordinary share

Purchase

278

2.4320

Ordinary share

Purchase

2,665

2.4260

Ordinary share

Purchase

363

2.4770

Ordinary share

Purchase

821

2.4600

Ordinary share

Purchase

1,353

2.4440

Ordinary share

Purchase

14,406

2.4290

Ordinary share

Purchase

2,499

2.4120

Ordinary share

Purchase

2,520

2.4270

Ordinary share

Purchase

2,373

2.4430

Ordinary share

Purchase

86

2.4550

Ordinary share

Purchase

2,501

2.4270

Ordinary share

Purchase

113

2.4340

Ordinary share

Purchase

1,878

2.4340

Ordinary share

Purchase

529

2.4720

Ordinary share

Purchase

622

2.4240

Ordinary share

Purchase

664

2.4760

Ordinary share

Purchase

192

2.4240

Ordinary share

Purchase

1,027

2.4120

Ordinary share

Purchase

2,530

2.4120

Ordinary share

Purchase

658

2.4720

Ordinary share

Purchase

1,154

2.4240

Ordinary share

Purchase

512

2.4320

Ordinary share

Purchase

649

2.4320

Ordinary share

Purchase

938

2.4320

Ordinary share

Purchase

2,584

2.4260

Ordinary share

Purchase

834

2.4380

Ordinary share

Purchase

666

2.4530

Ordinary share

Purchase

11,227

2.4270

Ordinary share

Purchase

2,654

2.4310

Ordinary share

Purchase

480

2.4220

Ordinary share

Purchase

1,003

2.4340

Ordinary share

Purchase

2,871

2.4600

Ordinary share

Purchase

1,931

2.4700

Ordinary share

Purchase

1,157

2.4420

Ordinary share

Purchase

137

2.4770

Ordinary share

Purchase

3,730

2.4260

Ordinary share

Purchase

353

2.4600

Ordinary share

Purchase

1,766

2.4350

Ordinary share

Purchase

2,645

2.4310

Ordinary share

Purchase

3,688

2.4310

Ordinary share

Purchase

192

2.4240

Ordinary share

Purchase

505

2.4240

Ordinary share

Purchase

3,107

2.4350

Ordinary share

Purchase

1,822

2.4320

Ordinary share

Purchase

389

2.4410

Ordinary share

Purchase

822

2.4550

Ordinary share

Purchase

1,438

2.4350

Ordinary share

Purchase

418

2.4190

Ordinary share

Purchase

2,620

2.4120

Ordinary share

Purchase

2,515

2.4430

Ordinary share

Purchase

2,547

2.4600

Ordinary share

Purchase

2,514

2.4260

Ordinary share

Purchase

2,499

2.4270

Ordinary share

Purchase

504

2.4310

Ordinary share

Purchase

663

2.4630

Ordinary share

Purchase

882

2.4580

Ordinary share

Purchase

190

2.4410

Ordinary share

Purchase

2,642

2.4600

Ordinary share

Purchase

2,204

2.4310

Ordinary share

Purchase

1,603

2.4120

Ordinary share

Sale

197

2.4240

Ordinary share

Sale

1,396

2.4380

Ordinary share

Sale

934

2.4350

Ordinary share

Sale

1,123

2.4380

Ordinary share

Sale

1,865

2.4420

Ordinary share

Sale

2,547

2.4380

Ordinary share

Sale

59

2.4450

Ordinary share

Sale

818

2.4520

Ordinary share

Sale

1,739

2.4380

Ordinary share

Sale

32

2.4510

Ordinary share

Sale

221

2.4520

Ordinary share

Sale

320

2.4370

Ordinary share

Sale

539

2.4560

Ordinary share

Sale

1,018

2.4350

Ordinary share

Sale

2,620

2.4500

Ordinary share

Sale

2,534

2.4430

Ordinary share

Sale

1,835

2.4350

Ordinary share

Sale

1,739

2.4170

Ordinary share

Sale

2,606

2.4430

Ordinary share

Sale

828

2.4700

Ordinary share

Sale

400

2.4340

Ordinary share

Sale

83

2.4500

Ordinary share

Sale

1,392

2.4380

Ordinary share

Sale

1,739

2.4350

Ordinary share

Sale

194

2.4260

Ordinary share

Sale

2,595

2.4260

Ordinary share

Sale

107

2.4370

Ordinary share

Sale

766

2.4670

Ordinary share

Sale

459

2.4770

Ordinary share

Sale

116

2.4270

Ordinary share

Sale

2,499

2.4500

Ordinary share

Sale

2,514

2.4390

Ordinary share

Sale

2,527

2.4460

Ordinary share

Sale

2,595

2.4640

Ordinary share

Sale

708

2.4550

Ordinary share

Sale

725

2.4750

Ordinary share

Sale

921

2.4520

Ordinary share

Sale

1

2.4490

Ordinary share

Sale

699

2.4770

Ordinary share

Sale

2,177

2.4370

Ordinary share

Sale

300

2.4220

Ordinary share

Sale

2,467

2.4390

Ordinary share

Sale

59

2.4400

Ordinary share

Sale

2,200

2.4390

Ordinary share

Sale

2,632

2.4640

Ordinary share

Sale

395

2.4370

Ordinary share

Sale

1,331

2.4300

Ordinary share

Sale

325

2.4390

Ordinary share

Sale

1,932

2.4330

Ordinary share

Sale

433

2.4330

Ordinary share

Sale

2,630

2.4500

Ordinary share

Sale

3

2.4330

Ordinary share

Sale

4

2.4380

Ordinary share

Sale

444

2.4330

Ordinary share

Sale

803

2.4270

Ordinary share

Sale

1,060

2.4340

Ordinary share

Sale

576

2.4750

Ordinary share

Sale

708

2.4800

Ordinary share

Sale

81

2.4560

Ordinary share

Sale

242

2.4350

Ordinary share

Sale

561

2.4390

Ordinary share

Sale

1,933

2.4260

Ordinary share

Sale

59

2.4340

Ordinary share

Sale

59

2.4330

Ordinary share

Sale

2,557

2.4330

Ordinary share

Sale

432

2.4500

Ordinary share

Sale

1,878

2.4410

Ordinary share

Sale

332

2.4390

Ordinary share

Sale

2,512

2.4260

Ordinary share

Sale

1,414

2.4390

Ordinary share

Sale

79

2.4500

Ordinary share

Sale

1,745

2.4510

Ordinary share

Sale

2,300

2.4270

Ordinary share

Sale

579

2.4700

Ordinary share

Sale

1,739

2.4550

Ordinary share

Sale

101

2.4350

Ordinary share

Sale

504

2.4220

Ordinary share

Sale

111

2.4530

Ordinary share

Sale

10

2.4380

Ordinary share

Sale

1,257

2.4530

Ordinary share

Sale

227

2.4520

Ordinary share

Sale

342

2.4490

Ordinary share

Sale

593

2.4320

Ordinary share

Sale

1,739

2.4340

Ordinary share

Sale

68

2.4420

Ordinary share

Sale

83

2.4320

Ordinary share

Sale

759

2.4490

Ordinary share

Sale

507

2.4510

Ordinary share

Sale

903

2.4300

Ordinary share

Sale

1,032

2.4350

Ordinary share

Sale

367

2.4370

Ordinary share

Sale

2,622

2.4640

Ordinary share

Sale

1,741

2.4390

Ordinary share

Sale

960

2.4270

Ordinary share

Sale

59

2.4400

Ordinary share

Sale

410

2.4260

Ordinary share

Sale

730

2.4420

Ordinary share

Sale

778

2.4550

Ordinary share

Sale

48

2.4340

Ordinary share

Sale

2,507

2.4390

Ordinary share

Sale

400

2.4220

Ordinary share

Sale

286

2.4510

Ordinary share

Sale

498

2.4500

Ordinary share

Sale

708

2.4680

Ordinary share

Sale

262

2.4380

Ordinary share

Sale

277

2.4390

Ordinary share

Sale

1,150

2.4750

Ordinary share

Sale

2,559

2.4430

Ordinary share

Sale

59

2.4350

Ordinary share

Sale

714

2.4750

Ordinary share

Sale

808

2.4800

Ordinary share

Sale

1,000

2.4360

Ordinary share

Sale

5

2.4380

Ordinary share

Sale

2,700

2.4430

Ordinary share

Sale

822

2.4690

Ordinary share

Sale

2,628

2.4640

Ordinary share

Sale

1,155

2.4380

Ordinary share

Sale

660

2.4810

Ordinary share

Sale

2,560

2.4460

Ordinary share

Sale

1,431

2.4380

Ordinary share

Sale

1,739

2.4380

Ordinary share

Sale

737

2.4670

Ordinary share

Sale

512

2.4350

Ordinary share

Sale

75

2.4500

Ordinary share

Sale

1,861

2.4220

Ordinary share

Sale

11

2.4240

Ordinary share

Sale

970

2.4490

Ordinary share

Sale

56

2.4290

Ordinary share

Sale

637

2.4530

Ordinary share

Sale

2,654

2.4460

Ordinary share

Sale

750

2.4750

Ordinary share

Sale

58

2.4770

Ordinary share

Sale

2,009

2.4220

Ordinary share

Sale

2,543

2.4420

Ordinary share

Sale

1,739

2.4350

Ordinary share

Sale

771

2.4750

Ordinary share

Sale

408

2.4300

Ordinary share

Sale

574

2.4390

Ordinary share

Sale

2,497

2.4220

Ordinary share

Sale

1,600

2.4500

Ordinary share

Sale

126

2.4490

Ordinary share

Sale

44

2.4340

Ordinary share

Sale

126

2.4320

Ordinary share

Sale

1,636

2.4220

Ordinary share

Sale

1,074

2.4370

Ordinary share

Sale

886

2.4300

Ordinary share

Sale

813

2.4750

Ordinary share

Sale

459

2.4220

Ordinary share

Sale

691

2.4680

Ordinary share

Sale

1,377

2.4320

Ordinary share

Sale

1,161

2.4380

Ordinary share

Sale

677

2.4560

Ordinary share

Sale

1,037

2.4660

Ordinary share

Sale

364

2.4490

Ordinary share

Sale

75

2.4390

Ordinary share

Sale

2,590

2.4460

Ordinary share

Sale

1,616

2.4300

Ordinary share

Sale

960

2.4270

Ordinary share

Sale

362

2.4340

Total purchases

138,668

Total sales

162,406

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit (GBP)

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

06/06/2013

Contact name:

Benoît Champion

Telephone number:

+44 20 7676 6280

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEOZMGGVLVFGFZG
161718192021222324
Date   Source Headline
11th Oct 20117:00 amRNSProposed Exercise of Option
5th Oct 201112:00 pmRNSDirector Declaration
28th Sep 20116:18 pmRNSConclusion of Corporate Governance Review
27th Sep 20119:00 amRNSSite Visit for Investors
17th Aug 20117:00 amRNSHalf Yearly Report
3rd Aug 20117:00 amRNSQ2 Production Report
20th Jun 20119:00 amRNSSite Visits
15th Jun 20117:00 amRNSResponse to press speculation - "ENRC"
8th Jun 20113:01 pmRNSReplacement: Result of AGM
8th Jun 20111:32 pmRNSResult of AGM
13th May 20113:40 pmRNSAnnual Information Update
12th May 20117:00 amRNSIMS and Q1 Production Report
3rd May 20114:51 pmRNSAnnual Financial Report
23rd Mar 20117:00 amRNSFinal Results
21st Mar 20114:29 pmRNSHolding(s) in Company
4th Feb 20113:07 pmRNSDirectorate Change
2nd Feb 20117:00 amRNSQ4 Production Report
31st Jan 201112:00 pmRNSExtension of Call Option
13th Jan 20113:26 pmRNSDirector/PDMR Shareholding
18th Nov 20103:23 pmRNSTR-1 Notification
11th Nov 20107:00 amRNSQ3 Production Report and IMS
19th Oct 20107:00 amRNSAcquisition
9th Sep 20107:00 amRNSStatement Re: Possible Legal Action
20th Aug 20103:32 pmRNSConference Call Re Acquisition
20th Aug 20103:32 pmRNSAcquisition
18th Aug 20107:00 amRNSHalf Yearly Report
13th Aug 201010:26 amRNSDirectorate Change
4th Aug 20107:00 amRNSQ2 Production Report
5th Jul 20109:57 amRNSDecision with regard to trade cancellation
5th Jul 20108:42 amRNSConsideration of Cancellation
22nd Jun 20107:00 amRNSSite Visits for Analysts
9th Jun 20103:43 pmRNSResult of AGM
27th May 20102:28 pmRNSAnnual Information Update
14th May 20103:34 pmRNSEuro Medium Term Note Prospectus
13th May 20107:00 amRNSIMS and Production Report
29th Apr 20104:00 pmRNSAnnual Financial Report
27th Apr 20102:06 pmRNSDirector/PDMR Shareholding
26th Apr 201012:02 pmRNSPurchase of 12.2% of Northam Platinum Ltd
1st Apr 20103:40 pmRNSDirector/PDMR Shareholding
29th Mar 20104:07 pmRNSDirector/PDMR Shareholding
25th Mar 20103:01 pmRNSDirector/PDMR Shareholding
24th Mar 20107:00 amRNSFinal Results
18th Feb 20107:00 amRNSAcquisition
3rd Feb 20107:00 amRNSProduction Report for 4th Quarter Ended 31 Dec 09
26th Jan 20105:34 pmRNSDirectorate Change
15th Dec 20097:00 amRNSFurther re Offer
8th Dec 20097:00 amRNSFurther re Offer
24th Nov 20097:00 amRNSENRC Ferrochrome Seminar
17th Nov 20095:52 pmRNSHolding(s) in Company
12th Nov 200910:49 amRNSHolding(s) in Company
161718192021222324

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
TYMN
Tyman
LSE
0.00%
JCH
Jpmorgan Clav
LSE
0.21%
SSE
SSE
LSE
0.16%
JLP
Jubilee Metals
LSE
0.68%
ATT
Allianz Technology Trust
LSE
1.86%
Trending
GST
GSTechnologies
LSE
4.55%
CPI
Capita
LSE
-17.77%
ITM
Itm Power
LSE
5.58%
QBT
Quantum Block
LSE
0.00%
GGP
Greatland Resources
LSE
3.57%